Genetic determinants of hepatitis B vaccine response
2011

Genetic Factors Affecting Hepatitis B Vaccine Response

Sample size: 4300 publication Evidence: moderate

Author Information

Author(s): Png Eileen, Thalamuthu Anbupalam, Ong Rick TH, Snippe Harm, Sudoyo Herawati, Muljono David H, Marzuki Sangkot, Boland Greet J, Seielstad Mark

Primary Institution: Genome Institute of Singapore

Hypothesis

There is genetic variation influencing the immune response to the hepatitis B vaccine.

Conclusion

The study identified several genetic regions associated with vaccine response in hepatitis B.

Supporting Evidence

  • Approximately one-third of the world’s population has serological evidence of hepatitis B virus infection.
  • 350 million people are carriers of chronic HBV infection.
  • About a million carriers die each year from chronic liver disease.
  • HBV is a vaccine preventable disease.
  • 10% of the population fails to mount a protective immune response after vaccination.
  • Twin studies suggest a high heritability of the vaccine response trait.
  • The study genotyped 2000 vaccinees in the first stage and 2300 in the second stage.

Takeaway

Some people don't respond well to the hepatitis B vaccine, and scientists are looking for genes that might explain why.

Methodology

A two-stage Genome Wide Association Scan (GWAS) was performed on participants from a vaccine efficacy trial.

Participant Demographics

Participants were vaccinees from Batam, Indonesia.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication